BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 12654425)

  • 1. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
    Marcus KJ; Dutton SC; Barnes P; Coleman CN; Pomeroy SL; Goumnerova L; Billett AL; Kieran M; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1182-5. PubMed ID: 12654425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma.
    Haas-Kogan DA; Banerjee A; Kocak M; Prados MD; Geyer JR; Fouladi M; McKnight T; Poussaint TY; Broniscer A; Blaney SM; Boyett JM; Kun LE
    Neuro Oncol; 2008 Jun; 10(3):341-7. PubMed ID: 18417739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma.
    Chang EL; Loeffler JS; Riese NE; Wen PY; Alexander E; Black PM; Coleman CN
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):65-70. PubMed ID: 9422559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
    Allen J; Siffert J; Donahue B; Nirenberg A; Jakacki R; Robertson P; DaRosso R; Thoron L; Rosovsky M; Pinto R
    Cancer; 1999 Sep; 86(6):1064-9. PubMed ID: 10491535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma.
    Broniscer A; Baker JN; Tagen M; Onar-Thomas A; Gilbertson RJ; Davidoff AM; Pai Panandiker AS; Leung W; Chin TK; Stewart CF; Kocak M; Rowland C; Merchant TE; Kaste SC; Gajjar A
    J Clin Oncol; 2010 Nov; 28(31):4762-8. PubMed ID: 20921456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952.
    Sanghavi SN; Needle MN; Krailo MD; Geyer JR; Ater J; Mehta MP
    Neuro Oncol; 2003 Jan; 5(1):8-13. PubMed ID: 12626128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group.
    Broniscer A; Leite CC; Lanchote VL; Machado TM; Cristófani LM
    J Clin Oncol; 2000 Mar; 18(6):1246-53. PubMed ID: 10715294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.
    Sullivan FJ; Herscher LL; Cook JA; Smith J; Steinberg SM; Epstein AH; Oldfield EH; Goffman TE; Kinsella TJ; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):583-90. PubMed ID: 7928489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
    Souweidane MM; Kramer K; Pandit-Taskar N; Zhou Z; Haque S; Zanzonico P; Carrasquillo JA; Lyashchenko SK; Thakur SB; Donzelli M; Turner RS; Lewis JS; Cheung NV; Larson SM; Dunkel IJ
    Lancet Oncol; 2018 Aug; 19(8):1040-1050. PubMed ID: 29914796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of etanidazole and radiotherapy in malignant glioma.
    Riese NE; Loeffler JS; Wen P; Alexander E; Black PM; Coleman CN
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):617-20. PubMed ID: 8005825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
    Werner-Wasik M; Scott CB; Nelson DF; Gaspar LE; Murray KJ; Fischbach JA; Nelson JS; Weinstein AS; Curran WJ
    Cancer; 1996 Apr; 77(8):1535-43. PubMed ID: 8608540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy.
    Mandell LR; Kadota R; Freeman C; Douglass EC; Fontanesi J; Cohen ME; Kovnar E; Burger P; Sanford RA; Kepner J; Friedman H; Kun LE
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):959-64. PubMed ID: 10192340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme.
    Del Rowe J; Scott C; Werner-Wasik M; Bahary JP; Curran WJ; Urtasun RC; Fisher B
    J Clin Oncol; 2000 Mar; 18(6):1254-9. PubMed ID: 10715295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.
    Pollack IF; Jakacki RI; Blaney SM; Hancock ML; Kieran MW; Phillips P; Kun LE; Friedman H; Packer R; Banerjee A; Geyer JR; Goldman S; Poussaint TY; Krasin MJ; Wang Y; Hayes M; Murgo A; Weiner S; Boyett JM
    Neuro Oncol; 2007 Apr; 9(2):145-60. PubMed ID: 17293590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of weekly topotecan combined to concurrent external cranial irradiation in adults with glioblastoma multiforme of the brain.
    Varveris H; Petinelli E; Stratakis J; Mazonakis M
    Oncol Rep; 2008 Feb; 19(2):447-55. PubMed ID: 18202794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer.
    Machtay M; Aviles V; Kligerman MM; Treat J; Weinstein GS; Weber RS; Mirza N; Chalian AA; Rosenthal DI
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):311-5. PubMed ID: 10760424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of cranial radiation therapy with concomitant continuous infusion paclitaxel in children with brain tumors.
    Liu L; Vapiwala N; Munoz LK; Winick NJ; Weitman S; Strauss LC; Frankel LS; Rosenthal DI
    Med Pediatr Oncol; 2001 Oct; 37(4):390-2. PubMed ID: 11568904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D conformal radiotherapy and cisplatin for recurrent malignant glioma.
    VanderSpek L; Fisher B; Bauman G; Macdonald D
    Can J Neurol Sci; 2008 Mar; 35(1):57-64. PubMed ID: 18380278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas?
    Freeman CR; Kepner J; Kun LE; Sanford RA; Kadota R; Mandell L; Friedman H
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):561-4. PubMed ID: 10837936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.